Immunomedics (IMMU)

25.35 +1.01 (4.15%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/15/18 *Est.)

Latest Headlines

Form 4 IMMUNOMEDICS INC For: Jun 15 Filed by: Aghazadeh Behzad June 19, 2018 4:07 PM - SEC Filing Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC June 19, 2018 4:06 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Jun 12 June 15, 2018 4:01 PM - SEC Filing Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC June 15, 2018 2:05 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Jun 15 Filed by: venBio Select Advisor LLC June 15, 2018 2:03 PM - SEC Filing Immunomedics Announces Closing of Public Offering of Common Stock June 15, 2018 11:40 AM - StreetInsider Immunomedics Announces Closing of Public Offering of Common Stock June 15, 2018 11:39 AM - Globe NewsWire Form 424B5 IMMUNOMEDICS INC June 14, 2018 6:02 AM - SEC Filing Immunomedics (IMMU) Prices 11.5M Share Common Offering at $24/Sh June 13, 2018 8:01 AM - StreetInsider Immunomedics Announces Pricing of Public Offering of Common Stock June 13, 2018 8:00 AM - Globe NewsWire Immunomedics Announces Pricing of Public Offering of Common Stock June 13, 2018 8:00 AM - StreetInsider Pre-Open Movers 06/12: (GLMD) (RH) (PLAY) Higher; (IDRA) (JCAP) (IMMU) Lower (more...) June 12, 2018 9:26 AM - StreetInsider After-Hours Stock Movers 06/11: (RH) (PLAY) (PFNX) Higher; (JCAP) (IMMU) (HOME) Lower (more...) June 11, 2018 5:27 PM - StreetInsider Form 424B5 IMMUNOMEDICS INC June 11, 2018 5:26 PM - SEC Filing Immunomedics Announces Proposed Public Offering of Common Stock June 11, 2018 4:14 PM - StreetInsider Immunomedics (IMMU) Commences $275 Million Offering of Common Stock June 11, 2018 4:13 PM - StreetInsider Immunomedics Announces Proposed Public Offering of Common Stock June 11, 2018 4:13 PM - Globe NewsWire Form S-3ASR IMMUNOMEDICS INC June 11, 2018 4:10 PM - SEC Filing Pre-Open Movers 06/07: (AVHI) (CONN) (FIVE) Higher; (MDXG) (PTI) (REVG) Lower (more...) June 7, 2018 9:29 AM - StreetInsider UPDATE: B.Riley/FBR Starts Immunomedics (IMMU) at Buy, Added to Alpha Generator List June 6, 2018 5:45 PM - StreetInsider Form SC 13D/A IMMUNOMEDICS INC Filed by: SEATTLE GENETICS INC /WA June 5, 2018 4:22 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Jun 04 June 4, 2018 10:13 AM - SEC Filing Pre-Open Movers 06/04: (VSAR) (VYGR) (GHDX) Higher; (NKTR) (JNCE) (CFX) Lower (more...) June 4, 2018 9:30 AM - StreetInsider Immunomedics (IMMU) Provides Business Update at ASCO Investor Event June 4, 2018 8:02 AM - StreetInsider Immunomedics (IMMU) PT Raised to $31 at Wells Fargo June 4, 2018 8:02 AM - StreetInsider Immunomedics Provides Business Update at the ASCO 2018 Investor Event June 4, 2018 8:00 AM - Globe NewsWire Immunomedics Provides Business Update at the ASCO 2018 Investor Event June 4, 2018 8:00 AM - StreetInsider Immunomedics (IMMU) PT Raised to $30 at Cowen June 4, 2018 6:24 AM - StreetInsider Immunomedics (IMMU) & Clovis Oncology (CLVS) Report Planned Clinical Collaboration to Study Combination Therapies June 4, 2018 6:18 AM - StreetInsider Form 8-K IMMUNOMEDICS INC For: Jun 01 June 4, 2018 6:07 AM - SEC Filing Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers June 3, 2018 8:00 PM - Globe NewsWire Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers June 3, 2018 8:00 PM - StreetInsider Immunomedics Reveals Promising Data for Sacituzumab Govitecan in Patients Heavily Pretreated for Metastatic Estrogen Receptor-Positive Breast Cancer June 3, 2018 10:15 AM - Globe NewsWire Immunomedics Reveals Promising Data for Sacituzumab Govitecan in Patients Heavily Pretreated for Metastatic Estrogen Receptor-Positive Breast Cancer June 3, 2018 10:15 AM - StreetInsider Immunomedics' (IMMU) option implied volatility flat into ASCO June 1, 2018 2:33 PM - StreetInsider Immunomedics (IMMU) Highlights Pivotal Study of Sacituzumab Govitecan June 1, 2018 8:07 AM - StreetInsider Immunomedics Announces Pivotal Study of Sacituzumab Govitecan in Patients With Locally Advanced or Metastatic Urothelial Cancer June 1, 2018 8:00 AM - Globe NewsWire Immunomedics Announces Pivotal Study of Sacituzumab Govitecan in Patients With Locally Advanced or Metastatic Urothelial Cancer June 1, 2018 8:00 AM - StreetInsider Immunomedics to Present at Jefferies 2018 Global Healthcare Conference May 30, 2018 8:00 AM - Globe NewsWire Immunomedics to Present at Jefferies 2018 Global Healthcare Conference May 30, 2018 8:00 AM - StreetInsider Immunomedics (IMMU) Submits BLA for Sacituzumab Govitecan to U.S. FDA May 21, 2018 8:05 AM - StreetInsider Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration May 21, 2018 8:00 AM - Globe NewsWire Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration May 21, 2018 8:00 AM - StreetInsider Form CT ORDER IMMUNOMEDICS INC May 18, 2018 2:32 PM - SEC Filing Pre-Open Movers 05/17: (WWE) (LOXO) (NTES) Higher; (JNCE) (JCP) (ACXM) Lower (more...) May 17, 2018 9:22 AM - StreetInsider Immunomedics' (IMMU) option implied volatility into ASCO May 17, 2018 6:36 AM - StreetInsider Immunomedics (IMMU) Reports Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer May 16, 2018 5:05 PM - StreetInsider Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer May 16, 2018 5:01 PM - Globe NewsWire Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer May 16, 2018 5:01 PM - StreetInsider Form 3 IMMUNOMEDICS INC For: Apr 12 Filed by: ROSENBERG MORRIS May 15, 2018 9:18 AM - SEC Filing Immunomedics (IMMU) PT Raised to $25 at Cowen May 10, 2018 1:15 AM - StreetInsider Form 10-Q IMMUNOMEDICS INC For: Mar 31 May 9, 2018 4:57 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: May 09 May 9, 2018 4:02 PM - SEC Filing Immunomedics (IMMU) Misses Q3 EPS by 6c May 9, 2018 4:01 PM - StreetInsider Immunomedics Announces Third Quarter Fiscal 2018 Results and Provides Corporate Update May 9, 2018 4:00 PM - Globe NewsWire Immunomedics Announces Third Quarter Fiscal 2018 Results and Provides Corporate Update May 9, 2018 4:00 PM - StreetInsider Immunomedics to Report Third Quarter Fiscal 2018 Results and Host Conference Call and Webcast on May 9, 2018 May 2, 2018 8:00 AM - Globe NewsWire Immunomedics to Report Third Quarter Fiscal 2018 Results and Host Conference Call and Webcast on May 9, 2018 May 2, 2018 8:00 AM - StreetInsider Immunomedics (IMMU) Announces Oral Presentation of Sacituzumab Govitecan in HR+ mBC at ASCO April 25, 2018 12:17 PM - StreetInsider Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting April 25, 2018 12:15 PM - Globe NewsWire Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting April 25, 2018 12:15 PM - StreetInsider Form 3 IMMUNOMEDICS INC For: Apr 12 Filed by: Malik Usama April 23, 2018 4:07 PM - SEC Filing Form 3 IMMUNOMEDICS INC For: Apr 12 Filed by: Iannone Robert April 23, 2018 4:06 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Apr 13 April 19, 2018 4:16 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Apr 09 April 13, 2018 5:01 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Apr 04 April 10, 2018 4:59 PM - SEC Filing Immunomedics (IMMU) Names Dr. Robert Iannone Head of Research & Development and CMO April 9, 2018 8:06 AM - StreetInsider Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer April 9, 2018 8:00 AM - Globe NewsWire Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer April 9, 2018 8:00 AM - StreetInsider Form 8-K IMMUNOMEDICS INC For: Apr 02 April 2, 2018 4:00 PM - SEC Filing Full Article List